Annales de Dermatologie et de Vénéréologie 1990-01-01

[Atopic dermatitis: role of oxatomide].

A Taieb

Index: Ann. Dermatol. Venereol. 117 Suppl 1 , 15-9, (1990)

Full Text: HTML

Abstract

Oxatomide is an antiallergic molecule which acts mainly as a calcium blocker. This article is a review of oxatomide treatment in atopic dermatitis patients. First, an overview of oxatomide treatment hypersensitivity reactions in atopic dermatitis and of their supposed immunologic mechanisms. The total number of patients treated so far in published studies is too low to fully appreciate the therapeutic benefit of this molecule. However, encouraging results were reported in two controlled studies and 3 open studies originating from four different groups. Tolerance was excellent (of 200 patients evaluated in 5 studies, transient sleepiness was noted in 5, and weight gain was noted in 3 children).

Related Compounds

Related Articles:

Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

2009-01-01

[Drugs 69(18) , 2541-76, (2009)]

Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.

2014-09-15

[Biochem. Pharmacol. 91(2) , 231-41, (2014)]

Molecular complexes of ketaconazole and oxatomide with p-chloranil: spectroscopic and spectrofluorimetric studies.

2011-09-01

[Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 79(5) , 1137-44, (2011)]

High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma.

2002-01-01

[Arzneimittelforschung 52(10) , 754-63, (2002)]

Effect of oxatomide, an antiallergic agent, on QT interval in dogs.

2001-01-01

[Arzneimittelforschung 51(12) , 971-6, (2001)]

More Articles...